Susceptibility of Clostridium difficile Isolates of Varying Antimicrobial Resistance Phenotypes to SMT19969 and 11 Comparators.
Antimicrob Agents Chemother. 2016 01; 60(1):689-92.AA

Abstract

We determined the in vitro activity of SMT19969 and 11 comparators, including metronidazole, vancomycin, and fidaxomicin, against 107 C. difficile isolates of different antimicrobial resistance phenotypes. Fidaxomicin and SMT19969 were the most active. The fidaxomicin and SMT19969 geometric mean MICs were highest in ribotypes known to show multiple resistance. Coresistance to linezolid and moxifloxacin was evident in ribotypes 001, 017, 027, and 356. The high-level ceftriaxone resistance in ribotypes 356 and 018 was location linked.

Links

Publisher Full Text
ncbi.nlm.nih.gov
aac.asm.org
aac.asm.org
PMC Free PDF

Authors+Show Affiliations

Freeman J
Microbiology, Leeds Teaching Hospitals Trust, University of Leeds, Leeds, United Kingdom Healthcare Associated Infections Research Group, Leeds Institute for Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
Vernon J
Healthcare Associated Infections Research Group, Leeds Institute for Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom.
Vickers R
Summit Therapeutics, Abingdon, Oxfordshire, United Kingdom.
Wilcox MH
Microbiology, Leeds Teaching Hospitals Trust, University of Leeds, Leeds, United Kingdom Healthcare Associated Infections Research Group, Leeds Institute for Biomedical and Clinical Sciences, University of Leeds, Leeds, United Kingdom mark.wilcox@nhs.net.

MeSH

AminoglycosidesAnti-Bacterial AgentsBenzimidazolesCeftriaxoneClostridioides difficileClostridium InfectionsDrug Resistance, Multiple, BacterialFidaxomicinFluoroquinolonesHumansLinezolidMetronidazoleMicrobial Sensitivity TestsMoxifloxacinPhenotypePyridinesRibotypingVancomycin

Pub Type(s)

Comparative Study
Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

26552981